PHC Holdings×M3×SMS×Jmdc
Different ways of making money, on the same scale.
Same yardstick
| Metric | PHC HoldingsFY ending Mar 2026 | M3FY ending Mar 2026 | SMSFY ending Mar 2026 | JmdcFY ending Mar 2026 |
|---|---|---|---|---|
| Revenue | ¥364.4B | ¥351.4B | ¥64.7B | ¥50.5B |
| COGS ratio | 54.6% | 50.0% | 11.7% | 45.1% |
| Operating margin | 6.2% | 20.9% | 10.5% | 20.8% |
| Net margin | 0.1% | 14.0% | -22.1% | 13.4% |
| FCF margin | 9.2% | 16.6% | 7.6% | 13.0% |
Highlighted = best value for that metric
Compare industry percentiles by axis
Each row uses the same 0–100 scale. Dots show each company's rank within its primary industry.
- PHC HoldingsPrimary industry: CRO & Clinical Testing
- M3Primary industry: Health Tech
- SMSPrimary industry: Health Tech
- JmdcPrimary industry: Health Tech
CompanyRank
Revenue growth
- PHC Holdings45.812 peers
- M353.614 peers
- SMS39.314 peers
- Jmdc89.314 peers
- PHC Holdings
Profitability
- PHC Holdings65.413 peers
- M369.418 peers
- SMS36.118 peers
- Jmdc63.918 peers
- PHC Holdings
Cash conversion
- PHC Holdings59.111 peers
- M379.417 peers
- SMS91.217 peers
- Jmdc44.117 peers
- PHC Holdings
Efficiency
- PHC Holdings42.313 peers
- M32518 peers
- SMS7518 peers
- Jmdc2.818 peers
- PHC Holdings
Financial strength
- PHC HoldingsN/A
- M3N/A
- SMSN/A
- JmdcN/A
- PHC Holdings
Each dot is a company's percentile within its primary industry; peer groups may differ. Missing axes are labeled as unavailable. No combined score is calculated, and industry rank is not an investment recommendation.
Money flows side by side
Chart height is proportional to revenue.
PHC Holdings¥364.4B · keeps ¥6 per ¥100
M3¥351.4B · keeps ¥21 per ¥100
SMS¥64.7B · keeps ¥10 per ¥100
Jmdc¥50.5B · keeps ¥21 per ¥100
Analyze this page with AI
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.